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A study was done to demonstrate quantitatively and 
graphically the way in which suberythemogenic doses of 
broadband UV A and UVB interact in producing a visible 
erythema. On the backs of fair-skinned human volun-
teers the minimal erythema dose (MED) was determined 
for polychromatic UV A and UVB. Increasing fractions 
of the UV A MED were given to sites already exposed to 
various fractions of the UVB MED resulting in sites 
exposed to various doses of both UV A and UVB. The 
saIIle experiment was repeated with the order of wave-
bands reversed. It was demonstrated that when UV A 
was followed by UVB an erythema was produced in 
those sites where the sum of the fractions was equal to 
one, an interaction termed photoaddition. When the 
UV A exposure followed the UVB, erythema was again 
predominantly noted in those sites demonstrating pho-
to addition. However, in the latter case, numerous sites 
of threshold erythema were noted where the sum of the 
fractions was- greater than one. This is suggestive of 
photorecovery. No evidence of photoaugmentation was 
observed with either order of exposut:.e. 
Ultr~violet radiation of wavelengths 320-400 nm (UV A) re-
quires at least 1,000 times more energy to produce delayed 
erythema of human skin than does ultraviolet radiation of 
wavelengths 290-320 nm (UVB) [1]. Yet, in many circum-
stances, UV A may make significant contributions to the pro-
duction of erythema. The amount of solar UV A reaching the 
earth's surface may be several hundred times greater than the 
amount of UVB. Many sunscreens that effectively block or 
diminish the highly erythemogenic UVB do not block UV A 
thus permitting prolonged sun exposw-es and even higher UV A 
expOsw·e doses. Late afternoon or early morning sun exposure, 
traditionally believed to be innocuous, contains a great amount 
of UV A, which may significantly contribute to sunburn incurred 
midday primarily by UVE. The quantitative manner in which 
UV A and UVB interact is important for other practical reasons 
such as developing safety standards for UV exposure, predicting 
the response to any radiation source based on consideration of 
the spectral power distribution and the human erythema action 
spectrum, and for calculating exposw-e doses in broadband UV 
phototherapy. 
There are 3 possible ways by which suberythemogenic doses 
of UV A and UVB could interact to produce a threshold ery-
thema: the sum of the fraction of the minimal erythema dose of 
UV A (MED A) and the fraction of the minimal eryth ema dose 
of UVB (MED B) can equal one, an interaction termed photoad-
dition; the sum can be less than one, an interaction called 
photoaugmentation; or the sum can be greater than one, an 
interaction called photoprotection or photorecovery. The li ter-
ature on this subject has fo und proponents for all 3 of these 
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phenomena [2-9]. Because of the fundamental importance of 
this question to photobiology, we performed an experiment 
designed to cal'efully quantitate and graphically demonstrate 
which of the above interactions indeed occm , 
MATERIALS AND METHODS 
Subjects 
Six healthy paid volunteer subjects prut icipated in this study. All 
had Type I skin, one had widespread vitiligo and all test.ing was done 
on vitiligo patches. Informed consent was obtained from each subject. 
Ultraviolet Sources 
The UVA source was a 2,500 w xenon ru·c with a f/ 1.5 quru·tz 
condensing lens system. Radiation was fil tered through 6 cm of an 
aqueous solution of a 7% CuSO" and 7% CoSO" in a qurutz based 
chamber and through a Schott WG 335 (l mm) fil ter. It was then 
projected onto the skin in a uniform (±10% circulru' field using a f / 4 
quartz lens and a UVA 45° dichroic mirror. Irradiance was 200 w/ m". 
Spectral irradiance of this soW"ce is shown in Fig I , as measured by an 
International Light IL 783 spectroradiometer. Wi th this soW"ce the 
UVB irradiation was at least 5 orders of magnitude less than the UVA 
irradiation. 
The UVB soW"ce was a 1.2 X 1.2 m planru' bank of closely spaced 
fluorescent sunlamp bulbs (FS40 Westinghouse). The ou t.put of this 
source was measured by a cosine corrected International Light UVB 
detector having a spectral responsivity weighted similarly to the action 
spectrum for delayed erythema. It had a biologically effective irradiance 
equivalent to 5.5 w/ m" at 290 nm. Uniformity was ±5%. Full spectral 
irradiance of this source is given in Fig 2 as m!fasured by an IL 783 
spectroradiometer. Essentially all effective erythema producing iTradia-
tion fTom the sOUJ"ce is UVB. 
Determination of the M.ED Dose 
The MED (minimal erythema dose) for UVA and UVB was deter-
mined for each subject. A series of eight 1 cm diameter circles ranging 
from 40 J / cm2 to 100 J / cm" of UVA and 15 mj/cm" to 40 mj/ cm" of 
UVB were exposed in 15% increments on the lower back. The sites 
were observed at 24 hr. The lowest exposure dose which resul ted in a 
minimal perceptible erythema was defined as the thl"eshold dose or 
MED for UVA (MEDA) and UVB (MEDu). 
Waveband Intera.ction 
An aluminum template of forty-nine 1 cm-diameter circles in a 7 x 
7 display (7 rows by 7 columns) was affixed to the lower back. The fU'st 
column received no UVA. The others received 1/ 6 MED", 2/ 6 MED,\, 
3/ 6MEDA , 4/ 6 MED", 5/ 6 MEP" and 1 MEDA respectively. UVB was 
then administered to the rows. The first row received no UVB, the 
others received 1/ 6 MEDB, 2/6 MEDB, 3/6 MEDs , 4/ 6 MEDs , 5/ 6 
MEDs, and 1 MEDs respectively in a grid-like fashion superimposed 
on the UVA exposUl"es. Hence, each exposw'e site received a different 
combination of fractions of MEDA and MEDs wi th the first column 
receiving only UVB and the fu·st row receiving only UVA (see Fig 3). 
Twenty-fow' houTs later each of the 49 exposw'e sites was read visually 
by at least two observers, recorded and photographed. The same 
process was then repeated on the opposite side of the lower back except 
the order was reversed with the UVB being given first followed by the 
UVA. 
RESULTS 
MED 
The average MEDB and MEDA for the 6 subjects was 22 
(range 17-26) mj / cm2 and 66 (range 46-80) J / cm2 respectively. 
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FIG 1. Spectral power distribution of UV A source (filtered xenon 
arc lamps). 
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FIG 2. Spectral power distribution of UVB source (FS40) . 
Waveband Interaction 
T h e fIrst subject developed considerable immediate pigment 
darkening from the UV A exposure which persisted at 24 hI' 
making it difficult to determine the erythema threshold points. 
Thereafter, only the lightest skin type I subjects and a subject 
with widespread vitiligo were exposed to minimize this effect. 
These 5 subjects demonstrated eryth ema threshold points pre-
dominantly in a line along the diagnonal in the exposures in 
which UVB was preceded by UVA (see Fig 4A). When the 
order was reversed with UV A being given after UVB the 
threshold points again occurred predominantly in a line along 
the diagonal although there was at least one instance in all 5 
subjects where the erythema threshold point was located in the 
line above the diagonal (see Fig 4B). The sign test has been 
used to test the hypothesis that the median of all erythema 
threshold points occur on the diagonal line. The result shows 
that the occurrence of eryth ema threshold points in the line 
above the diagonal is not statistically s ignificant (p = 0.055). 
DISCUSSION 
These results demonstrate that when suberythemogenic 
UVB is given after suberythemogenic UV A they interact by 
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photoaddition in producing a threshold erythema. When the 
order is reversed and UVB is given first, the interaction again 
is predominantly photoaddition although there is a suggestion 
of mild photorecovery. No evidence of photoaugmentat ion was 
noted with either sequence of radiation . 
To maximize the quantitative accuracy and interpretability 
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FIG 3. Experimental design. Each of the 49 exposure sites received 
a different combination of UV A and UVB. The points along the 
diagonal line from the lower left to the upper right are those which 
, received sums of MED fractions equal to one (solid line) . Threshold 
erythema occurring along this line is evidence for photoaddition. The 
points above or to the left of this line received a sum of greater than 
one and threshold erythema occurring in this area is evidence for 
photorecovery. One pattern of minimal photorecovery would be rep-
resented by (--). More striking photorecovery would place the 
threshold values further to the left upper portion of the design. The 
points below or to the right of the solid diagonal line received a 
combination totalling less than one, threshold erythema points in this 
region represent photoaugmentation. A pattern of minimal photoaug-
mentation is represented by (---). 
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FIG 4. The encircled numbers represent how many of the 5 fair 
subjects demonstrated a minimal perceptible (threshold) erythema in 
that circle. All empty circles below these sites received less than 
threshold and demonstrated no erythema. Empty circles above received 
greater than threshold and showed erythema. Note that in Fig 4A, 
UVB following UV A exposure, the great predominance of threshold 
points are along the diagonal at the sites where the sum of the fractions 
are equal to one. In Fig 4B, UV A following UVB exposure, a number 
of threshold points occurred in the line above the diagonal. 
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of this study, MED's for UV A and UVB were carefully deter-
mined in all subjects in the area immediately adjacent to the 
experimental site. The experiment was carried out on the day 
following the MED determinations. While it is difficult to 
accurately differentiate gradations of erythema visually, t he 
determination of the presence or absence of erythema is more 
precise, repeatable and agreed upon by observers. In addition, 
the difference in dose-response curve for UV A and UVB ery-
thema, makes the interpretation of suprathreshold interactions 
even more difficult . Therefore, a minimal perceptible erythema 
was used as the endpoint or threshold erythema. 
The previous literature on this interaction is often difficult to 
interpret. van der Leun and Stoop [2] noted that 5 hr of indirect 
sunlight filtered through windowglass increased by 20 to 30% 
the amount of previously given 250 nm and 300 nm radiation 
needed to produce an MED. This demonstrates photorecovery 
but because they did not quantitate the UVA given in the five 
hour exposure or calculate what percent this was of the MED A, 
the degree of photorecovery is unknown. When they reversed 
the order of exposures, giving the sunlight first, they report a 
decrease in the MED 2GO and MED3oo. Similarly, it is not clear 
whether this was a photoadditive or photoaugmentative effect. 
Van Weelden [3] also demonstrated photorecovery when UV A 
was given following either UVB or UVC. Reversing the order 
showed photoaddition when UVC followed UV A exposure, and 
slight photoaugmentation when UVB followed UV A. The pho-
toaugmentation noted was not statistically significant. Willis, 
Kligman, and Epstein [4] claimed to observe photoaugmenta-
tion. After their subjects were given a fixed dose of UVA, only 
25% or 50% of the MEDB was needed to produce an erythema. 
Again this data is difficult to interpret because they did not 
quantitate the MEDA in each subject. It ~ noteworthy that the 
two subjects whose MEDB was reduced the most had the lowest 
initial MEDn and therefore probably the lowest MEDA. Since 
the UVA exposures were fixed, one can infer that these subjects 
received a higher percentage of their MEDA. If it were as high 
as 3/4 of the MEDA then the results could be explained by 
photoaddition. Reversing the UV exposure order was not done 
in this study. 
In a follow-up study Kaidbey and Kligman [5] combined 
fractions of the determined MEDB to 10, 15 and 20 min of UV A. 
Although they did mention that their source causes redness in 
the average subject after 60 min of exposure, they did not 
calculate the MEDA for each subject and so it is not known 
what fraction of the MEDA was given. A study by Spiegel et al 
[6] noted that 14 of 17 subjects demonstrated an erythema at 
24 hr when 7.5 J /cm 2 of UVA was given before or after one-half 
of the MED or UVE. Again the MED for UV A was not 
determined. A similar problem arises in a recent study of Boer, 
Schothorst, and Suurmond [7]. They noted that the MEDB was 
reduced by 20% when combined with a prior irradiation of 10 
J / cm2 ofUV A. They termed this photoaugmentation. However, 
if the MEDA with then' source was approximately 50 J /cm2 
their results would then be best described as photoaddition. 
They did not reverse the order of exposure. Yirig, Parrish, and 
Pathak [8] found photoaddition to be the case for UV A and 
UVB regardless of the order given. However, when UVB was 
given prior to UVA, only one dose of UV A was used, combined 
with fractions of the MEDB. With such limited exposure com-
binations it is doubtful that the mild photorecovery effect 
observed in our study would have been discernible to them. 
Sayre, Olson, and Everett [9] using a monochrometer showed 
that combined exposures to wavelengths 254 nm, 280 nm, and 
297 nm caused photoaddition for delayed erythema. Using 14 
different combinations of these wavelengths, the average of the 
sum of the fractions needed to produce a minimal erythema 
was 0.98. 
In the presented work, we are measuring the interaction of 
suberythemal doses of UV. It is an important concept that even 
at these suberythemal doses there are biological changes in the 
skin. Studies have shown that the suberythemal doses of UVB 
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[10] and UVA [4] cause DNA damage, inducing an increase of 
H3-Thymidine sparsely labeled cells, which signilles DNA re-
pan'. In both cases this DNA damage occurred at doses too 
small to cause histologic changes or erythema. Suberythemal 
doses of UVB can cause sunburn cell production [ll]. Subery-
themal doses of UV A can cause delayed melanogenesis in 
contrast to UVB which requires erythemal doses to produce 
melanogenesis [12]. Finally suberythemal doses of both UVB 
and UV A given at 24 hr intervals appear to have a cumulative 
effect resulting in the lowerin g of the erythema threshold [12]. 
The photoadditive and mildly photoprotective interactions 
herein described are only certain for the production ofthreshold 
erythema. It has been suggested that UV A does not enhance 
UVB-induced sunburn cell production [ll]. Interactions be-
tween UVA and UVB in causing DNA damage or melanogen-
esis have not yet been well quantified for human skin. 
When studying the interaction of UV A and UVB in the 
production of erythema, one must remember that the skin's 
biological response to UV A and UVB are different. UVB ery-
thema can be induced with about 20-50 mj/ cm2, peaks at 12-20 
hr, has a modest dose-response curve, and is superficial, pink-
red and easily blanched. UV A erythema requn'es more than 
1,000 times more energy, i.e. about 50-100 J / cm2 , may peak 
sooner, has a steeper dose response curve, and is deep-red to 
violaceous requn'ing firm pressure to blanch out. One possible 
reason for these differences is that the erythemas are being 
produced by different mechanisms. UV A and UVB may be 
absorbed by different chromophores setting off a different chain 
of events leading to erythema. Because of less epidermal ab-
sorption and less dermal scattering, UV A penetrates much 
more deeply into the dermis than UVB [13]. Erythemogenic 
doses of UV A cause primarily vessel damage and a dermal 
infiltrate; equally erythemogenic doses of UVB cause mainly 
epidermal changes such as dyskeratotic sunburn cells [14]. The 
mediators may also be different as evidenced by the fact that 
indomethacin will cause temporary blanching of a UVB-in-
duced erythema but not a UV A induced erythema [15]. This 
implies that prostaglandine may mediate part of the UVB 
erythema but not the UV A erythema. UV A as well as visible 
light may also produce immediate pigment darkening (IPD). 
This is believed to be due to the photooxidation of preformed 
melanin and in general is greater in subjects with more facula-
tive or constitutive pigment [1]. The IPD that we noted was 
often quite mm'ked and persistent, eventually blending into the 
delayed tanning. We noted no evidence that IPD is photopro-
tective. 
No immediate erythema was noted with UVA or UVB. This 
differs from a previous study [16] which noted significant im-
mediate erythema from UV A which persisted and blended into 
delayed erythema with no diphasic response. This difference 
may be related to the fact that the UV A in-adiance in the above 
study was considerably higher than ours. 
The suggestion of photorecovery which occw'S when UV A 
exposure follows UVB is very interesting. It should be empha-
sized that this means that the UVB erythema may be increased 
by subsequent UV A exposure, but not as much as would be 
predicted by their addition. There is now evidence which sug-
gests that human epidermal cells contain photoreactivating 
enzyme [17]. This enzyme in the presence of UVA or visible 
light repan's thymine dimers which can be caused by prior UVB 
exposure. The relationship, if any, ofUV-induced DNA damage 
and repair to erythema production is not known. However, it is 
possible that UV A, by hastening DNA repan', lessens the ery-
thema response. 
Although the mechanism and mediators of UV A and UVB 
erythema production and their interaction are still largely un-
known, we have shown clinically that they interact predomi-
nantly via photoaddition to produce a threshold erythema. 
Photorecovery is suggested in the case when UV A follows UVB 
exposure and further studies m'e in progress to confirm this. 
There was no evidence of photoaugmentation. 
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